High throughput screen in a co-culture model to uncover therapeutic strategies to potentiate the cancer-inhibiting properties of the tumor-stroma in pancreatic cancer
Mason, J. E.; Cumming, J.; Eriksson, A. U.; Binder, C.; Dongre, M.; Patthey, C.; Espona-Fiedler, M.; Chorell, E.; Ohlund, D.
Show abstract
Pancreatic stellate cells (PSCs) differentiate into multiple subtypes of cancer associated fibroblasts (CAFs) that modulate disease progression in pancreatic ductal adenocarcinoma (PDAC). CAF subtypes demonstrate functional heterogeneity in tumor development, with conflicting consequences for disease progression. Here, we show that myofibroblastic CAFs (myCAFs), but not inflammatory CAFs (iCAFs), can act to restrain tumor cell growth in an in vitro PDAC model of tumor organoids co-cultured with PSCs. Inhibiting myCAF formation by TGF-{beta} pathway inhibition improved tumor organoid growth, indicating that manipulating the balance of CAF subtypes may be exploited as a therapeutic approach. We therefore conducted a high throughput screen of approximately 36,000 compounds on the co-culture model to find novel compounds to inhibit PDAC tumor cell growth via CAF manipulation. We identify a new role for GNF-5, a known Abelson tyrosine kinase (Abl) inhibitor, in the context of PDAC as a compound that inhibits tumor cell growth in co-culture; an effect that was accompanied by an induction of the myCAF phenotype around tumor organoids. This highlights the therapeutic potential of novel therapies targeting specific CAF subtypes in PDAC.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A suspension technique for efficient large-scale cancer organoid culturing and perturbation screens 96%
- Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indications in a common base culture media system 95%
- Rapid Resistance To Bet Inhibitors Is Mediated By Fgfr1 In Glioblastoma 94%
Similar papers in this journal
- A novel triptolide analog downregulates NF-κB and induces mitochondrial apoptosis pathways in human pancreatic cancer 96%
- Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer 95%
- ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1 95%
Similar papers in this journal
- RAS/PI3K pathway mutations sensitise epithelial ovarian cancer cells to a PARP/NAMPT inhibitor combination 94%
- Indirect CRISPR screening with photoconversion revealed key factors of drug resistance with cell-cell interactions 94%
- Ribonucleotide Reductase Subunit Switching in Hepatoblastoma Drug Response and Relapse 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.